ClearBridge Investments’s Viking Therapeutics VKTX Stock Holding History

ClearBridge Investments’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4M	Hold	444,781	–	–	0.01%	440
2026 Q1	$14.5M	Sell	444,781 -59	-0%	-$1.9K	0.01%	434
2025 Q4	$15.6M	Buy	444,840 +630	+0.1%	+$22.3K	0.01%	445
2025 Q3	$11.7M	Sell	444,210 -187,143	-30%	-$5.58M	0.01%	482
2025 Q2	$16.7M	Sell	631,353 -607	-0.1%	-$16K	0.01%	432
2025 Q1	$15.3M	Sell	631,960 -8,158	-1%	-$258K	0.01%	438
2024 Q4	$25.8M	Sell	640,118 -98,456	-13%	-$5.61M	0.02%	409
2024 Q3	$46.8M	Buy	738,574 +153,973	+26%	+$9.03M	0.04%	337
2024 Q2	$31M	Sell	584,601 -12,588	-2%	-$825K	0.03%	398
2024 Q1	$49M	Buy	+597,189	New	+$26.6M	0.04%	340

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ClearBridge Investments's VKTX Position: Q2 2026 in Review

ClearBridge Investments held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 444,781 shares worth $17.4M. The position accounts for 0.01% of the portfolio, ranked #440.

ClearBridge Investments first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $49M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

ClearBridge Investments held 444,781 shares of Viking Therapeutics worth $17.4M as of Q2 2026.
ClearBridge Investments left its Viking Therapeutics share count unchanged in Q2 2026.
Viking Therapeutics made up 0.01% of ClearBridge Investments's portfolio in Q2 2026, its #440 holding.
ClearBridge Investments first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
ClearBridge Investments's Viking Therapeutics position peaked at $49M in Q1 2024.
432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.